Peripheral sensory neuropathy and cisplatin chemotherapy.
about
Interventions for preventing neuropathy caused by cisplatin and related compoundsInterventions for preventing neuropathy caused by cisplatin and related compoundsInterventions for preventing neuropathy caused by cisplatin and related compoundsInterventions for preventing neuropathy caused by cisplatin and related compoundsNeuropathic cancer pain: What we are dealing with? How to manage it?Persistence of cisplatin-induced DNA interstrand crosslinking in peripheral blood mononuclear cells from elderly and young individualsEvaluation by somatosensory evoked potentials of the neurotoxicity of cisplatin alone or in combination with glutathioneIncidence of neuropathy in 395 patients with ovarian cancer treated with or without cisplatinDifferential expression of ATP7A, ATP7B and CTR1 in adult rat dorsal root ganglion tissueMembrane transporters as mediators of Cisplatin effects and side effects.Calpain immunoreactivity and morphological damage in chinchilla inner ears after carboplatinDYRK1A genetic variants are not linked to Alzheimer's disease in a Spanish case-control cohort.Raynaud's phenomenon after combination chemotherapy of testicular cancer, measured by laser Doppler flowmetry. A pilot studyErythropoietin overrides the triggering effect of DNA platination products in a mouse model of cisplatin-induced neuropathy.No association of CDK5 genetic variants with Alzheimer's disease risk.EPIC: an effective low toxicity regimen for relapsing lymphoma.Caspase-1 genetic variation is not associated with Alzheimer's disease riskCisplatin neuropathy with Lhermitte's signSevere sensorimotor neuropathy after cisplatin therapy.Pathophysiology of Chemotherapy-Induced Peripheral Neuropathy.Cisplatin-based therapy: a neurological and neuropsychological review.Peripheral neuropathy in cancer patients.Electron microscopy in rat brain slices reveals rapid accumulation of Cisplatin on ribosomes and other cellular components only in gliaClinical course and risk factors of neurotoxicity following cisplatin in an intensive dosing schedule.Neurologic complications of bladder carcinoma: a review of 359 cases.Neurotoxicity caused by the treatment with platinum analogues.Genetic association of CYP46 and risk for Alzheimer's disease.Relationship between the exposure to cisplatin, DNA-adduct formation in leucocytes and tumour response in patients with solid tumoursPeripheral neuropathies from chemotherapeutics and targeted agents: diagnosis, treatment, and prevention.Unilateral Cervical Polyneuropathies following Concurrent Bortezomib, Cetuximab, and Radiotherapy for Head and Neck Cancer.Behavioral and electrophysiological studies in rats with cisplatin-induced chemoneuropathyMice with cisplatin and oxaliplatin-induced painful neuropathy develop distinct early responses to thermal stimuliTreatment of oxaliplatin-induced peripheral neuropathy by intravenous mangafodipir.AAEM minimonograph #34: polyneuropathy: classification by nerve conduction studies and electromyography.The double-edged sword: Neurotoxicity of chemotherapy.Increased regional cerebral glucose metabolism and semantic memory performance in Alzheimer's disease: a pilot double blind transdermal nicotine positron emission tomography study.Role of transporters in the distribution of platinum-based drugs.Pharmacotherapeutic options for treating adverse effects of Cisplatin chemotherapy.The Role of Transporters in the Toxicity of Chemotherapeutic Drugs: Focus on Transporters for Organic Cations.Oral alpha-lipoic acid to prevent chemotherapy-induced peripheral neuropathy: a randomized, double-blind, placebo-controlled trial.
P2860
Q24197763-8C387DAD-02BB-4B12-B48C-1A6B776BB4B4Q24236661-22B6AE34-C49D-4EA4-A796-49D4438BB714Q24244693-905AE9F5-75D1-4CF2-AC4D-4729201D00F9Q24246530-5B139148-9375-4250-A0D3-1051B661B2D9Q26998945-A94B6967-0AD2-4445-A57C-CEE61F550F00Q28305738-C2A75C0E-B1BE-4F6C-83D7-D328F4450E43Q28327147-9575E784-EBB1-4093-826C-7A23E86A572AQ28329582-C7FCAA4C-968B-4A9B-9FC2-AA1F7C9F0B9CQ28564651-A58AF00C-25FF-46AE-A05A-8F4BF863163BQ30446860-EFB17DD3-25DC-4AA8-9CE4-7E807949C52FQ30473509-3989ADA6-5032-4B4D-BB60-6FF21779F20BQ30967631-2B6828A8-EF5C-4508-87FB-10FC1633E41BQ33337998-B903AECC-ACD9-493D-9FFD-BCEE3A2DB83BQ33482074-99DD8E62-F818-4165-B6D7-1A8C80CAEA75Q33483663-5BA0BA46-685D-4E1D-867A-5EE8DD8FA0E0Q33493801-BEF862BB-7BD2-4330-83B7-E8720B9A1595Q33534445-6C88EA68-31A2-4873-BF31-0C1E4E878E5BQ33621865-910DE3FF-4055-4BAD-957A-F0797162E678Q33622080-9532E2EB-1507-4A8D-9E35-97727C4AE83BQ33744706-245E7F56-D848-4B94-8178-CC2C81B17C00Q33833882-C94EFB96-6420-45A5-8A94-57F0FEDA89A8Q34280846-F8B31DB8-9680-4E2B-BAD6-7B285BD28403Q34919954-C3AB7FA8-D2F4-4164-80E8-9FCFEE2CD47AQ35055517-38306540-BF49-490E-8FFF-AE8DD1E0FE3AQ35113831-52289ECB-D58C-4775-89E8-EBB116ADA468Q35692169-DD4B48DE-E642-4500-8E4A-648ABF75BC88Q35852204-5C7037CB-6001-4A6B-BE52-5EA21961229DQ36135407-153E3CDF-A328-4FF8-AE63-4EF755E7C13DQ36344699-69A267B7-DC34-4A17-A498-A18B02AD86E6Q36759636-C316A859-6082-4FC1-9EA3-8B48B43E516CQ37071711-71433065-FCE2-4227-8294-78E1B8DB1C40Q37127360-1F24E09F-5813-4A28-ACC3-7294B4BB20CDQ37410573-984A1F8E-C106-4455-B88F-FC751C676A11Q37897506-EF4DCC01-76F6-474A-AD8B-9858ABF94AA7Q38274890-8923D1A3-5538-4F34-A16B-7AA4350DFE84Q38459906-DE583A88-C277-47D4-89F0-A625D7582E8CQ38474594-E1C3BAB9-4306-44EF-8110-E89A92590987Q38637751-A39BC5EE-B3D6-4F76-8503-DEAFBE3B3313Q38888345-2CBE1DB3-197C-416C-A7D9-99DBFD039F89Q39289330-0162CACC-0D4E-426E-AA2D-C0865B614B87
P2860
Peripheral sensory neuropathy and cisplatin chemotherapy.
description
1984 nî lūn-bûn
@nan
1984年の論文
@ja
1984年論文
@yue
1984年論文
@zh-hant
1984年論文
@zh-hk
1984年論文
@zh-mo
1984年論文
@zh-tw
1984年论文
@wuu
1984年论文
@zh
1984年论文
@zh-cn
name
Peripheral sensory neuropathy and cisplatin chemotherapy.
@en
Peripheral sensory neuropathy and cisplatin chemotherapy.
@nl
type
label
Peripheral sensory neuropathy and cisplatin chemotherapy.
@en
Peripheral sensory neuropathy and cisplatin chemotherapy.
@nl
prefLabel
Peripheral sensory neuropathy and cisplatin chemotherapy.
@en
Peripheral sensory neuropathy and cisplatin chemotherapy.
@nl
P2093
P356
P1433
P1476
Peripheral sensory neuropathy and cisplatin chemotherapy.
@en
P2093
Hrushesky W
Roelofs RI
Rosenberg L
P304
P356
10.1212/WNL.34.7.934
P407
P577
1984-07-01T00:00:00Z